Wallerian degeneration: Gaining perspective on inflammatory events after peripheral nerve injury

Journal of Neuroinflammation

Volumn 8, Issue , 2011, Pages

  Gaudet, Andrew D ^a,b   Popovich, Phillip G ^a   Ramer, Matt S ^b  

^a THE OHIO STATE UNIVERSITY COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Aaxotomy; Galectin 1; Inflammation; Macrophage; Microgli; Neuroinflammation; Phagocytosis; Spinal cord injury; Wallerian degeneration

Indexed keywords

CYTOKINE; GROWTH FACTOR;

APOPTOSIS; BLOOD NERVE BARRIER; CELL PERMEABILIZATION; CELL PROLIFERATION; CENTRAL NERVOUS SYSTEM; CYTOKINE RELEASE; DENERVATION; EXTRACELLULAR MATRIX; HUMAN; IMMUNOCOMPETENT CELL; INFLAMMATION; MACROPHAGE; MONOCYTE; MYELINATION; NERVE DEGENERATION; NERVE FIBER DEGENERATION; NERVE FIBER REGENERATION; PERIPHERAL NERVE INJURY; PHAGOCYTOSIS; RECEPTOR SENSITIVITY; REMYELINIZATION; REVIEW; SCAR FORMATION; SCHWANN CELL; SPINAL CORD INJURY; TISSUE INJURY; TISSUE REACTION; TISSUE REPAIR; ANIMAL; CYTOLOGY; IMMUNOLOGY; METABOLISM; NERVE FIBER; NERVE REGENERATION; PATHOLOGY; PHYSIOLOGY;

ANIMALS; AXONS; HUMANS; INFLAMMATION; NERVE REGENERATION; PERIPHERAL NERVE INJURIES; SCHWANN CELLS; WALLERIAN DEGENERATION;

EID: 80052118069     PISSN: None     EISSN: 17422094     Source Type: Journal    
DOI: 10.1186/1742-2094-8-110     Document Type: Review

References (170)

1. Alfred RH, Jacobs RL. Der Welk Arm (The Withered Arm). The Iowa Orthopaedic Journal 1986, 6:87-89.
2. Ober WB. Obstetrical events that shaped Western European history. Yale J Biol Med 1992, 65:201-210. 2589601, 1285448.
3. Jain V, Sebire NJ, Talbert DG. Kaiser Wilhelm syndrome: obstetric trauma or placental insult in a historical case mimicking Erb's palsy. Med Hypotheses 2005, 65:185-191. 10.1016/j.mehy.2004.12.027, 15893138.
4. Langley JN, Hashimoto M. On the suture of separate nerve bundles in a nerve trunk and on internal nerve plexuses. J Physiol 1917, 51:318-346. 1402701, 16993388.
5. Jobe MT, Martinez SF. Peripheral Nerve Injuries. Campbell's Operative Orthopaedics 2007, Mosby, Canale ST, Beaty JH, 3160910, 21887281.
6. Seddon H. The use of autogenous grafts for the repair of large gaps in peripheral nerves. British Journal of Surgery 1947, 35:151-167. 10.1002/bjs.18003513808, 20271763.
7. Woodhall B, Beebe G. Peripheral Nerve Regeneration: A Follow-Up Study of 3,656 World War II Injuries 1956, Washington, DC: US Government Printing Office.
8. Abe N, Cavalli V. Nerve injury signaling. Curr Opin Neurobiol 2008, 18:276-283. 10.1016/j.conb.2008.06.005, 2633416, 18655834.
9. Fenrich K, Gordon T. Canadian Association of Neuroscience review: axonal regeneration in the peripheral and central nervous systems--current issues and advances. Can J Neurol Sci 2004, 31:142-156.
10. Shim S, Ming GL. Roles of channels and receptors in the growth cone during PNS axonal regeneration. Exp Neurol 2010, 223:38-44. 10.1016/j.expneurol.2009.10.001, 2849920, 19833126.
11. Waller A. Experiments on the section of the glossopharyngeal and hypoglossal nerves of the frog, and observations of the alterations produced thereby in the structure of their primitive fibres. Philosophical Transactions of the Royal Society of London 1850, 140:423-429.
12. Stoll G, Jander S, Myers RR. Degeneration and regeneration of the peripheral nervous system: from Augustus Waller's observations to neuroinflammation. J Peripher Nerv Syst 2002, 7:13-27. 10.1046/j.1529-8027.2002.02002.x, 11939348.
13. Griffin JW, George EB, Hsieh S-T, Glass JD. Axonal degeneration and disorders of the axonal cytoskeleton. The Axon: Structure, Function and Pathophysiology 1995, 375-390. New York: Oxford University Press, Waxman SG, Kocsis JD, Stys PK.
14. Griffin JW, Thompson WJ. Biology and pathology of nonmyelinating Schwann cells. Glia 2008, 56:1518-1531. 10.1002/glia.20778, 18803315.
15. Vargas ME, Barres BA. Why is Wallerian degeneration in the CNS so slow?. Annu Rev Neurosci 2007, 30:153-179. 10.1146/annurev.neuro.30.051606.094354, 17506644.
16. Luttges MW, Kelly PT, Gerren RA. Degenerative changes in mouse sciatic nerves: electrophoretic and electrophysiologic characterizations. Exp Neurol 1976, 50:706-733. 10.1016/0014-4886(76)90039-X, 176052.
17. Tsao JW, George EB, Griffin JW. Temperature modulation reveals three distinct stages of Wallerian degeneration. J Neurosci 1999, 19:4718-4726.
18. Lubinska L. Early course of Wallerian degeneration in myelinated fibres of the rat phrenic nerve. Brain Res 1977, 130:47-63. 10.1016/0006-8993(77)90841-1, 884520.
19. Miledi R, Slater CR. On the degeneration of rat neuromuscular junctions after nerve section. J Physiol 1970, 207:507-528. 1348721, 5499034.
20. Beirowski B, Adalbert R, Wagner D, Grumme DS, Addicks K, Ribchester RR, Coleman MP. The progressive nature of Wallerian degeneration in wild-type and slow Wallerian degeneration (WldS) nerves. BMC Neurosci 2005, 6:6. 10.1186/1471-2202-6-6, 549193, 15686598.
21. Chaudhry V, Cornblath DR. Wallerian degeneration in human nerves: serial electrophysiological studies. Muscle Nerve 1992, 15:687-693. 10.1002/mus.880150610, 1324426.
22. Gilliatt RW, Hjorth RJ. Nerve conduction during Wallerian degeneration in the baboon. J Neurol Neurosurg Psychiatry 1972, 35:335-341. 10.1136/jnnp.35.3.335, 494074, 4624688.
23. George EB, Glass JD, Griffin JW. Axotomy-induced axonal degeneration is mediated by calcium influx through ion-specific channels. J Neurosci 1995, 15:6445-6452.
24. Sievers C, Platt N, Perry VH, Coleman MP, Conforti L. Neurites undergoing Wallerian degeneration show an apoptotic-like process with Annexin V positive staining and loss of mitochondrial membrane potential. Neurosci Res 2003, 46:161-169. 10.1016/S0168-0102(03)00039-7, 12767479.
25. Kerschensteiner M, Schwab ME, Lichtman JW, Misgeld T. In vivo imaging of axonal degeneration and regeneration in the injured spinal cord. Nat Med 2005, 11:572-577. 10.1038/nm1229, 15821747.
26. Nikolaeva MA, Mukherjee B, Stys PK. Na+-dependent sources of intra-axonal Ca2+ release in rat optic nerve during in vitro chemical ischemia. J Neurosci 2005, 25:9960-9967. 10.1523/JNEUROSCI.2003-05.2005, 16251444.
27. Stirling DP, Stys PK. Mechanisms of axonal injury: internodal nanocomplexes and calcium deregulation. Trends Mol Med 2010, 16:160-170. 10.1016/j.molmed.2010.02.002, 2976657, 20207196.
28. Wang MS, Davis AA, Culver DG, Wang Q, Powers JC, Glass JD. Calpain inhibition protects against Taxol-induced sensory neuropathy. Brain 2004, 127:671-679.
29. Touma E, Kato S, Fukui K, Koike T. Calpain-mediated cleavage of collapsin response mediator protein(CRMP)-2 during neurite degeneration in mice. Eur J Neurosci 2007, 26:3368-3381. 10.1111/j.1460-9568.2007.05943.x, 18052987.
30. Zhai Q, Wang J, Kim A, Liu Q, Watts R, Hoopfer E, Mitchison T, Luo L, He Z. Involvement of the ubiquitin-proteasome system in the early stages of wallerian degeneration. Neuron 2003, 39:217-225. 10.1016/S0896-6273(03)00429-X, 12873380.
31. Coleman MP, Freeman MR. Wallerian degeneration, wld(s), and nmnat. Annu Rev Neurosci 2010, 33:245-267. 10.1146/annurev-neuro-060909-153248, 20345246.
32. Lunn ER, Perry VH, Brown MC, Rosen H, Gordon S. Absence of Wallerian Degeneration does not Hinder Regeneration in Peripheral Nerve. Eur J Neurosci 1989, 1:27-33. 10.1111/j.1460-9568.1989.tb00771.x, 12106171.
33. Babetto E, Beirowski B, Janeckova L, Brown R, Gilley J, Thomson D, Ribchester RR, Coleman MP. Targeting NMNAT1 to axons and synapses transforms its neuroprotective potency in vivo. J Neurosci 2010, 30:13291-13304. 10.1523/JNEUROSCI.1189-10.2010, 20926655.
34. Perry VH, Brown MC, Tsao JW. The Effectiveness of the Gene Which Slows the Rate of Wallerian Degeneration in C57BL/Ola Mice Declines With Age. Eur J Neurosci 1992, 4:1000-1002. 10.1111/j.1460-9568.1992.tb00126.x, 12106435.
35. Glass JD, Brushart TM, George EB, Griffin JW. Prolonged survival of transected nerve fibres in C57BL/Ola mice is an intrinsic characteristic of the axon. J Neurocytol 1993, 22:311-321. 10.1007/BF01195555, 8315413.
36. Conforti L, Tarlton A, Mack TG, Mi W, Buckmaster EA, Wagner D, Perry VH, Coleman MP. A Ufd2/D4Cole1e chimeric protein and overexpression of Rbp7 in the slow Wallerian degeneration (WldS) mouse. Proc Natl Acad Sci USA 2000, 97:11377-11382. 17208, 11027338.
37. Mack TG, Reiner M, Beirowski B, Mi W, Emanuelli M, Wagner D, Thomson D, Gillingwater T, Court F, Conforti L, Fernando FS, Tarlton A, Andressen C, Addicks K, Magni G, Ribchester RR, Perry VH, Coleman MP. Wallerian degeneration of injured axons and synapses is delayed by a Ube4b/Nmnat chimeric gene. Nat Neurosci 2001, 4:1199-1206.
38. Bisby MA, Chen S. Delayed wallerian degeneration in sciatic nerves of C57BL/Ola mice is associated with impaired regeneration of sensory axons. Brain Res 1990, 530:117-120. 10.1016/0006-8993(90)90666-Y, 2271939.
39. Popovich PG, Horner PJ, Mullin BB, Stokes BT. A quantitative spatial analysis of the blood-spinal cord barrier. I. Permeability changes after experimental spinal contusion injury. Exp Neurol 1996, 142:258-275. 10.1006/exnr.1996.0196, 8934558.
40. Weerasuriya A, Mizisin AP. The blood-nerve barrier: structure and functional significance. Methods Mol Biol 2011, 686:149-173. 10.1007/978-1-60761-938-3_6, 21082370.
41. Olsson Y. Topographical differences in the vascular permeability of the peripheral nervous system. Acta Neuropathol 1968, 10:26-33. 10.1007/BF00690507, 5640115.
42. Orozco OE, Walus L, Sah DW, Pepinsky RB, Sanicola M. GFRalpha3 is expressed predominantly in nociceptive sensory neurons. Eur J Neurosci 2001, 13:2177-2182. 10.1046/j.0953-816x.2001.01596.x, 11422460.
43. Smith CE, Atchabahian A, Mackinnon SE, Hunter DA. Development of the blood-nerve barrier in neonatal rats. Microsurgery 2001, 21:290-297. 10.1002/micr.1055, 11754428.
44. Gray M, Palispis W, Popovich PG, van Rooijen N, Gupta R. Macrophage depletion alters the blood-nerve barrier without affecting Schwann cell function after neural injury. J Neurosci Res 2007, 85:766-777. 10.1002/jnr.21166, 17266098.
45. Weerasuriya A, Hockman CH. Perineurial permeability to sodium during Wallerian degeneration in rat sciatic nerve. Brain Res 1992, 581:327-333. 10.1016/0006-8993(92)90727-Q, 1466671.
46. Mizisin AP, Weerasuriya A. Homeostatic regulation of the endoneurial microenvironment during development, aging and in response to trauma, disease and toxic insult. Acta Neuropathol 2011, 121:291-312. 10.1007/s00401-010-0783-x, 3038236, 21136068.
47. S Ramon y C. Cajal's Degeneration & Regeneration of the Nervous System 1991, New York: Oxford University Press, 3160328, 21886841.
48. Campana WM. Schwann cells: activated peripheral glia and their role in neuropathic pain. Brain Behav Immun 2007, 21:522-527. 10.1016/j.bbi.2006.12.008, 2219463, 17321718.
49. Lee HK, Shin YK, Jung J, Seo SY, Baek SY, Park HT. Proteasome inhibition suppresses Schwann cell dedifferentiation in vitro and in vivo. Glia 2009, 57:1825-1834. 10.1002/glia.20894, 19455715.
50. Guertin AD, Zhang DP, Mak KS, Alberta JA, Kim HA. Microanatomy of axon/glial signaling during Wallerian degeneration. J Neurosci 2005, 25:3478-3487. 10.1523/JNEUROSCI.3766-04.2005, 15800203.
51. Liu HM, Yang LH, Yang YJ. Schwann cell properties: 3. C-fos expression, bFGF production, phagocytosis and proliferation during Wallerian degeneration. J Neuropathol Exp Neurol 1995, 54:487-496. 10.1097/00005072-199507000-00002, 7602323.
52. Murinson BB, Archer DR, Li Y, Griffin JW. Degeneration of myelinated efferent fibers prompts mitosis in Remak Schwann cells of uninjured C-fiber afferents. J Neurosci 2005, 25:1179-1187. 10.1523/JNEUROSCI.1372-04.2005, 15689554.
53. Trapp BD, Hauer P, Lemke G. Axonal regulation of myelin protein mRNA levels in actively myelinating Schwann cells. J Neurosci 1988, 8:3515-3521.
54. White FV, Toews AD, Goodrum JF, Novicki DL, Bouldin TW, Morell P. Lipid metabolism during early stages of Wallerian degeneration in the rat sciatic nerve. J Neurochem 1989, 52:1085-1092. 10.1111/j.1471-4159.1989.tb01851.x, 2926390.
55. Pellegrino RG, Politis MJ, Ritchie JM, Spencer PS. Events in degenerating cat peripheral nerve: induction of Schwann cell S phase and its relation to nerve fibre degeneration. J Neurocytol 1986, 15:17-28. 10.1007/BF02057901, 3086507.
56. Stoll G, Griffin JW, Li CY, Trapp BD. Wallerian degeneration in the peripheral nervous system: participation of both Schwann cells and macrophages in myelin degradation. J Neurocytol 1989, 18:671-683. 10.1007/BF01187086, 2614485.
57. Medzhitov R. Toll-like receptors and innate immunity. Nat Rev Immunol 2001, 1:135-145. 10.1038/35100529, 11905821.
58. Vabulas RM, Ahmad-Nejad P, da CC, Miethke T, Kirschning CJ, Hacker H, Wagner H. Endocytosed HSP60s use toll-like receptor 2 (TLR2) and TLR4 to activate the toll/interleukin-1 receptor signaling pathway in innate immune cells. J Biol Chem 2001, 276:31332-31339. 10.1074/jbc.M103217200, 11402040.
59. Kariko K, Ni H, Capodici J, Lamphier M, Weissman D. mRNA is an endogenous ligand for Toll-like receptor 3. J Biol Chem 2004, 279:12542-12550.
60. Brunn GJ, Bungum MK, Johnson GB, Platt JL. Conditional signaling by Toll-like receptor 4. FASEB J 2005, 19:872-874.
61. Goethals S, Ydens E, Timmerman V, Janssens S. Toll-like receptor expression in the peripheral nerve. Glia 2010, 58:1701-1709. 10.1002/glia.21041, 20578041.
62. Lee H, Jo EK, Choi SY, Oh SB, Park K, Kim JS, Lee SJ. Necrotic neuronal cells induce inflammatory Schwann cell activation via TLR2 and TLR3: implication in Wallerian degeneration. Biochem Biophys Res Commun 2006, 350:742-747. 10.1016/j.bbrc.2006.09.108, 17027917.
63. Karanth S, Yang G, Yeh J, Richardson PM. Nature of signals that initiate the immune response during Wallerian degeneration of peripheral nerves. Exp Neurol 2006, 202:161-166. 10.1016/j.expneurol.2006.05.024, 16828744.
64. Boivin A, Pineau I, Barrette B, Filali M, Vallieres N, Rivest S, Lacroix S. Toll-like receptor signaling is critical for Wallerian degeneration and functional recovery after peripheral nerve injury. J Neurosci 2007, 27:12565-12576. 10.1523/JNEUROSCI.3027-07.2007, 18003835.
65. Pineau I, Lacroix S. Endogenous signals initiating inflammation in the injured nervous system. Glia 2009, 57:351-361. 10.1002/glia.20763, 18803306.
66. Huang JK, Phillips GR, Roth AD, Pedraza L, Shan W, Belkaid W, Mi S, Fex-Svenningsen A, Florens L, Yates JR, Colman DR. Glial membranes at the node of Ranvier prevent neurite outgrowth. Science 2005, 310:1813-1817. 10.1126/science.1118313, 16293723.
67. Shen ZL, Lassner F, Bader A, Becker M, Walter GF, Berger A. Cellular activity of resident macrophages during Wallerian degeneration. Microsurgery 2000, 20:255-261. 10.1002/1098-2752(2000)20:5<255::AID-MICR6>3.0.CO;2-A, 11015722.
68. Meyer zu HG, Hu W, Hartung HP, Lehmann HC, Kieseier BC. The immunocompetence of Schwann cells. Muscle Nerve 2008, 37:3-13. 10.1002/mus.20893, 17823955.
69. Hirata K, Mitoma H, Ueno N, He JW, Kawabuchi M. Differential response of macrophage subpopulations to myelin degradation in the injured rat sciatic nerve. J Neurocytol 1999, 28:685-695. 10.1023/A:1007012916530, 10851347.
70. Holtzman E, Novikoff AB. Lysomes in the rat sciatic nerve following crush. J Cell Biol 1965, 27:651-669. 10.1083/jcb.27.3.651, 2106775, 5885432.
71. Perry VH, Tsao JW, Fearn S, Brown MC. Radiation-induced reductions in macrophage recruitment have only slight effects on myelin degeneration in sectioned peripheral nerves of mice. Eur J Neurosci 1995, 7:271-280. 10.1111/j.1460-9568.1995.tb01063.x, 7538855.
72. Martini R, Fischer S, Lopez-Vales R, David S. Interactions between Schwann cells and macrophages in injury and inherited demyelinating disease. Glia 2008, 56:1566-1577. 10.1002/glia.20766, 18803324.
73. Ribardo DA, Crowe SE, Kuhl KR, Peterson JW, Chopra AK. Prostaglandin levels in stimulated macrophages are controlled by phospholipase A2-activating protein and by activation of phospholipase C and D. J Biol Chem 2001, 276:5467-5475. 10.1074/jbc.M006690200, 11094054.
74. De S, Trigueros MA, Kalyvas A, David S. Phospholipase A2 plays an important role in myelin breakdown and phagocytosis during Wallerian degeneration. Mol Cell Neurosci 2003, 24:753-765. 10.1016/S1044-7431(03)00241-0, 14664823.
75. Shamash S, Reichert F, Rotshenker S. The cytokine network of Wallerian degeneration: tumor necrosis factor-alpha, interleukin-1alpha, and interleukin-1beta. J Neurosci 2002, 22:3052-3060.
76. Kurek JB, Austin L, Cheema SS, Bartlett PF, Murphy M. Up-regulation of leukaemia inhibitory factor and interleukin-6 in transected sciatic nerve and muscle following denervation. Neuromuscul Disord 1996, 6:105-114. 10.1016/0960-8966(95)00029-1, 8664561.
77. Bolin LM, Verity AN, Silver JE, Shooter EM, Abrams JS. Interleukin-6 production by Schwann cells and induction in sciatic nerve injury. J Neurochem 1995, 64:850-858.
78. Bourde O, Kiefer R, Toyka KV, Hartung HP. Quantification of interleukin-6 mRNA in wallerian degeneration by competitive reverse transcription polymerase chain reaction. J Neuroimmunol 1996, 69:135-140.
79. Banner LR, Patterson PH. Major changes in the expression of the mRNAs for cholinergic differentiation factor/leukemia inhibitory factor and its receptor after injury to adult peripheral nerves and ganglia. Proc Natl Acad Sci USA 1994, 91:7109-7113. 10.1073/pnas.91.15.7109, 44348, 8041754.
80. Tofaris GK, Patterson PH, Jessen KR, Mirsky R. Denervated Schwann cells attract macrophages by secretion of leukemia inhibitory factor (LIF) and monocyte chemoattractant protein-1 in a process regulated by interleukin-6 and LIF. J Neurosci 2002, 22:6696-6703.
81. Subang MC, Richardson PM. Influence of injury and cytokines on synthesis of monocyte chemoattractant protein-1 mRNA in peripheral nervous tissue. Eur J Neurosci 2001, 13:521-528. 10.1046/j.1460-9568.2001.01425.x, 11168559.
82. Shubayev VI, Angert M, Dolkas J, Campana WM, Palenscar K, Myers RR. TNFalpha-induced MMP-9 promotes macrophage recruitment into injured peripheral nerve. Mol Cell Neurosci 2006, 31:407-415. 10.1016/j.mcn.2005.10.011, 16297636.
83. Chen ZL, Yu WM, Strickland S. Peripheral regeneration. Annu Rev Neurosci 2007, 30:209-233. 10.1146/annurev.neuro.30.051606.094337, 17341159.
84. Patton BL, Miner JH, Chiu AY, Sanes JR. Distribution and function of laminins in the neuromuscular system of developing, adult, and mutant mice. J Cell Biol 1997, 139:1507-1521. 10.1083/jcb.139.6.1507, 2132624, 9396756.
85. Wallquist W, Patarroyo M, Thams S, Carlstedt T, Stark B, Cullheim S, Hammarberg H. Laminin chains in rat and human peripheral nerve: distribution and regulation during development and after axonal injury. J Comp Neurol 2002, 454:284-293. 10.1002/cne.10434, 12442319.
86. Chen ZL, Strickland S. Laminin gamma1 is critical for Schwann cell differentiation, axon myelination, and regeneration in the peripheral nerve. J Cell Biol 2003, 163:889-899. 10.1083/jcb.200307068, 2173689, 14638863.
87. Colognato H, ffrench-Constant C, Feltri ML. Human diseases reveal novel roles for neural laminins. Trends Neurosci 2005, 28:480-486. 10.1016/j.tins.2005.07.004, 16043237.
88. Gardiner NJ, Fernyhough P, Tomlinson DR, Mayer U, von der MH, Streuli CH. Alpha7 integrin mediates neurite outgrowth of distinct populations of adult sensory neurons. Mol Cell Neurosci 2005, 28:229-240. 10.1016/j.mcn.2004.08.017, 15691705.
89. Nodari A, Previtali SC, Dati G, Occhi S, Court FA, Colombelli C, Zambroni D, Dina G, Del CU, Campbell KP, Quattrini A, Wrabetz L, Feltri ML. Alpha6beta4 integrin and dystroglycan cooperate to stabilize the myelin sheath. J Neurosci 2008, 28:6714-6719. 10.1523/JNEUROSCI.0326-08.2008, 2597422, 18579745.
90. Murphy PG, Grondin J, Altares M, Richardson PM. Induction of interleukin-6 in axotomized sensory neurons. J Neurosci 1995, 15:5130-5138.
91. Cafferty WB, Gardiner NJ, Das P, Qiu J, McMahon SB, Thompson SW. Conditioning injury-induced spinal axon regeneration fails in interleukin-6 knock-out mice. J Neurosci 2004, 24:4432-4443. 10.1523/JNEUROSCI.2245-02.2004, 15128857.
92. Cao Z, Gao Y, Bryson JB, Hou J, Chaudhry N, Siddiq M, Martinez J, Spencer T, Carmel J, Hart RB, Filbin MT. The cytokine interleukin-6 is sufficient but not necessary to mimic the peripheral conditioning lesion effect on axonal growth. J Neurosci 2006, 26:5565-5573. 10.1523/JNEUROSCI.0815-06.2006, 16707807.
93. Heumann R, Lindholm D, Bandtlow C, Meyer M, Radeke MJ, Misko TP, Shooter E, Thoenen H. Differential regulation of mRNA encoding nerve growth factor and its receptor in rat sciatic nerve during development, degeneration, and regeneration: role of macrophages. Proc Natl Acad Sci USA 1987, 84:8735-8739. 10.1073/pnas.84.23.8735, 299621, 2825206.
94. Snider WD, Zhou FQ, Zhong J, Markus A. Signaling the pathway to regeneration. Neuron 2002, 35:13-16. 10.1016/S0896-6273(02)00762-6, 12123603.
95. Markus A, Patel TD, Snider WD. Neurotrophic factors and axonal growth. Curr Opin Neurobiol 2002, 12:523-531. 10.1016/S0959-4388(02)00372-0, 12367631.
96. Fu SY, Gordon T. The cellular and molecular basis of peripheral nerve regeneration. Mol Neurobiol 1997, 14:67-116. 10.1007/BF02740621, 9170101.
97. Scott AL, Ramer MS. Schwann cell p75NTR prevents spontaneous sensory reinnervation of the adult spinal cord. Brain 2010, 133:421-432. 10.1093/brain/awp316, 20047901.
98. Diamond J, Foerster A, Holmes M, Coughlin M. Sensory nerves in adult rats regenerate and restore sensory function to the skin independently of endogenous NGF. J Neurosci 1992, 12:1467-1476.
99. Diamond J, Coughlin M, Macintyre L, Holmes M, Visheau B. Evidence that endogenous beta nerve growth factor is responsible for the collateral sprouting, but not the regeneration, of nociceptive axons in adult rats. Proc Natl Acad Sci USA 1987, 84:6596-6600. 10.1073/pnas.84.18.6596, 299126, 3306683.
100. Mahanthappa NK, Anton ES, Matthew WD. Glial growth factor 2, a soluble neuregulin, directly increases Schwann cell motility and indirectly promotes neurite outgrowth. J Neurosci 1996, 16:4673-4683.
101. Fricker FR, Lago N, Balarajah S, Tsantoulas C, Tanna S, Zhu N, Fageiry SK, Jenkins M, Garratt AN, Birchmeier C, Bennett DL. Axonally derived Neuregulin-1 is required for remyelination and regeneration after nerve injury in adulthood. J Neurosci 2011, 31:3225-3233. 10.1523/JNEUROSCI.2568-10.2011, 3059576, 21368034.
102. Liu HM, Yang LH, Yang YJ. Schwann cell properties: 3. C-fos expression, bFGF production, phagocytosis and proliferation during Wallerian degeneration. J Neuropathol Exp Neurol 1995, 54:487-496. 10.1097/00005072-199507000-00002, 7602323.
103. Sulaiman OA, Gordon T. Effects of short- and long-term Schwann cell denervation on peripheral nerve regeneration, myelination, and size. Glia 2000, 32:234-246. 10.1002/1098-1136(200012)32:3<234::AID-GLIA40>3.0.CO;2-3, 11102965.
104. Dedkov EI, Kostrominova TY, Borisov AB, Carlson BM. Survival of Schwann cells in chronically denervated skeletal muscles. Acta Neuropathol 2002, 103:565-574. 10.1007/s00401-001-0504-6, 12012088.
105. Sulaiman OA, Gordon T. Transforming growth factor-beta and forskolin attenuate the adverse effects of long-term Schwann cell denervation on peripheral nerve regeneration in vivo. Glia 2002, 37:206-218. 10.1002/glia.10022, 11857679.
106. Li H, Terenghi G, Hall SM. Effects of delayed re-innervation on the expression of c-erbB receptors by chronically denervated rat Schwann cells in vivo. Glia 1997, 20:333-347. 10.1002/(SICI)1098-1136(199708)20:4<333::AID-GLIA6>3.0.CO;2-6, 9262237.
107. Nathan C. Neutrophils and immunity: challenges and opportunities. Nat Rev Immunol 2006, 6:173-182. 10.1038/nri1785, 16498448.
108. Perkins NM, Tracey DJ. Hyperalgesia due to nerve injury: role of neutrophils. Neuroscience 2000, 101:745-757. 10.1016/S0306-4522(00)00396-1, 11113323.
109. Kennedy AD, DeLeo FR. Neutrophil apoptosis and the resolution of infection. Immunol Res 2009, 43:25-61. 10.1007/s12026-008-8049-6, 19066741.
110. Mueller M, Leonhard C, Wacker K, Ringelstein EB, Okabe M, Hickey WF, Kiefer R. Macrophage response to peripheral nerve injury: the quantitative contribution of resident and hematogenous macrophages. Lab Invest 2003, 83:175-185.
111. Perry VH, Brown MC, Gordon S. The macrophage response to central and peripheral nerve injury. A possible role for macrophages in regeneration. J Exp Med 1987, 165:1218-1223. 10.1084/jem.165.4.1218, 2188570, 3559478.
112. Vass K, Hickey WF, Schmidt RE, Lassmann H. Bone marrow-derived elements in the peripheral nervous system. An immunohistochemical and ultrastructural investigation in chimeric rats. Lab Invest 1993, 69:275-282.
113. Bruck W, Friede RL. The role of complement in myelin phagocytosis during PNS wallerian degeneration. J Neurol Sci 1991, 103:182-187. 10.1016/0022-510X(91)90162-Z, 1880536.
114. Bonnekoh PG, Scheidt P, Friede RL. Myelin phagocytosis by peritoneal macrophages in organ cultures of mouse peripheral nerve. A new model for studying myelin phagocytosis in vitro. J Neuropathol Exp Neurol 1989, 48:140-153. 10.1097/00005072-198903000-00002, 2921613.
115. Mueller M, Wacker K, Ringelstein EB, Hickey WF, Imai Y, Kiefer R. Rapid response of identified resident endoneurial macrophages to nerve injury. Am J Pathol 2001, 159:2187-2197. 10.1016/S0002-9440(10)63070-2, 1850587, 11733369.
116. Siebert H, Sachse A, Kuziel WA, Maeda N, Bruck W. The chemokine receptor CCR2 is involved in macrophage recruitment to the injured peripheral nervous system. J Neuroimmunol 2000, 110:177-185. 10.1016/S0165-5728(00)00343-X, 11024548.
117. Vargas ME, Watanabe J, Singh SJ, Robinson WH, Barres BA. Endogenous antibodies promote rapid myelin clearance and effective axon regeneration after nerve injury. Proc Natl Acad Sci USA 2010, 107:11993-11998. 10.1073/pnas.1001948107, 2900702, 20547838.
118. Liu L, Lioudyno M, Tao R, Eriksson P, Svensson M, Aldskogius H. Hereditary absence of complement C5 in adult mice influences Wallerian degeneration, but not retrograde responses, following injury to peripheral nerve. J Peripher Nerv Syst 1999, 4:123-133.
119. Bouldin TW, Earnhardt TS, Goines ND. Restoration of blood-nerve barrier in neuropathy is associated with axonal regeneration and remyelination. J Neuropathol Exp Neurol 1991, 50:719-728. 10.1097/00005072-199111000-00004, 1748880.
120. Bruck W, Friede RL. Anti-macrophage CR3 antibody blocks myelin phagocytosis by macrophages in vitro. Acta Neuropathol 1990, 80:415-418. 10.1007/BF00307696, 2239153.
121. Bruck W. The role of macrophages in Wallerian degeneration. Brain Pathol 1997, 7:741-752. 10.1111/j.1750-3639.1997.tb01060.x, 9161725.
122. Gaudet AD, Leung M, Poirier F, Kadoya T, Horie H, Ramer MS. A role for galectin-1 in the immune response to peripheral nerve injury. Exp Neurol 2009, 220:320-327. 10.1016/j.expneurol.2009.09.007, 19766118.
123. Malik RK, Ghurye RR, Lawrence-Watt DJ, Stewart HJ. Galectin-1 stimulates monocyte chemotaxis via the p44/42 MAP kinase pathway and a pertussis toxin-sensitive pathway. Glycobiology 2009, 19:1402-1407. 10.1093/glycob/cwp077, 19561030.
124. Horie H, Kadoya T, Hikawa N, Sango K, Inoue H, Takeshita K, Asawa R, Hiroi T, Sato M, Yoshioka T, Ishikawa Y. Oxidized galectin-1 stimulates macrophages to promote axonal regeneration in peripheral nerves after axotomy. J Neurosci 2004, 24:1873-1880. 10.1523/JNEUROSCI.4483-03.2004, 14985427.
125. Gaudet AD, Steeves JD, Tetzlaff W, Ramer MS. Expression and functions of galectin-1 in sensory and motoneurons. Curr Drug Targets 2005, 6:419-425. 10.2174/1389450054021864, 16026260.
126. Horie H, Inagaki Y, Sohma Y, Nozawa R, Okawa K, Hasegawa M, Muramatsu N, Kawano H, Horie M, Koyama H, Sakai I, Takeshita K, Kowada Y, Takano M, Kadoya T. Galectin-1 regulates initial axonal growth in peripheral nerves after axotomy. J Neurosci 1999, 19:9964-9974.
127. McGraw J, McPhail LT, Oschipok LW, Horie H, Poirier F, Steeves JD, Ramer MS, Tetzlaff W. Galectin-1 in regenerating motoneurons. Eur J Neurosci 2004, 20:2872-2880. 10.1111/j.1460-9568.2004.03802.x, 15579141.
128. Beuche W, Friede RL. The role of non-resident cells in Wallerian degeneration. J Neurocytol 1984, 13:767-796. 10.1007/BF01148493, 6512566.
129. Bruck W, Huitinga I, Dijkstra CD. Liposome-mediated monocyte depletion during wallerian degeneration defines the role of hematogenous phagocytes in myelin removal. J Neurosci Res 1996, 46:477-484. 10.1002/(SICI)1097-4547(19961115)46:4<477::AID-JNR9>3.0.CO;2-D, 8950707.
130. La Fleur M, Underwood JL, Rappolee DA, Werb Z. Basement membrane and repair of injury to peripheral nerve: defining a potential role for macrophages, matrix metalloproteinases, and tissue inhibitor of metalloproteinases-1. J Exp Med 1996, 184:2311-2326. 10.1084/jem.184.6.2311, 2196375, 8976186.
131. Hikawa N, Takenaka T. Myelin-stimulated macrophages release neurotrophic factors for adult dorsal root ganglion neurons in culture. Cell Mol Neurobiol 1996, 16:517-528. 10.1007/BF02150231, 8879753.
132. Luk HW, Noble LJ, Werb Z. Macrophages contribute to the maintenance of stable regenerating neurites following peripheral nerve injury. J Neurosci Res 2003, 73:644-658. 10.1002/jnr.10701, 2792202, 12929132.
133. Kuhlmann T, Bitsch A, Stadelmann C, Siebert H, Bruck W. Macrophages are eliminated from the injured peripheral nerve via local apoptosis and circulation to regional lymph nodes and the spleen. J Neurosci 2001, 21:3401-3408.
134. Fry EJ, Ho C, David S. A role for Nogo receptor in macrophage clearance from injured peripheral nerve. Neuron 2007, 53:649-662. 10.1016/j.neuron.2007.02.009, 17329206.
135. Gitik M, Liraz-Zaltsman S, Oldenborg PA, Reichert F, Rotshenker S. Myelin down-regulates myelin phagocytosis by microglia and macrophages through interactions between CD47 on myelin and SIRPalpha (signal regulatory protein-alpha) on phagocytes. J Neuroinflammation 2011, 8:24. 10.1186/1742-2094-8-24, 3068094, 21401967.
136. Moalem G, Xu K, Yu L. T lymphocytes play a role in neuropathic pain following peripheral nerve injury in rats. Neuroscience 2004, 129:767-777. 10.1016/j.neuroscience.2004.08.035, 15541898.
137. Mosmann TR, Cherwinski H, Bond MW, Giedlin MA, Coffman RL. Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins. J Immunol 1986, 136:2348-2357.
138. London CA, Abbas AK, Kelso A. Helper T cell subsets: heterogeneity, functions and development. Vet Immunol Immunopathol 1998, 63:37-44. 10.1016/S0165-2427(98)00080-4, 9656439.
139. Xin J, Wainwright DA, Mesnard NA, Serpe CJ, Sanders VM, Jones KJ. IL-10 within the CNS is necessary for CD4(+) T cells to mediate neuroprotection. Brain Behav Immun 2011, 25:820-829. 10.1016/j.bbi.2010.08.004, 20723599.
140. Beahrs T, Tanzer L, Sanders VM, Jones KJ. Functional recovery and facial motoneuron survival are influenced by immunodeficiency in crush-axotomized mice. Exp Neurol 2010, 221:225-230. 10.1016/j.expneurol.2009.11.003, 2812661, 19913014.
141. Barrette B, Hebert MA, Filali M, Lafortune K, Vallieres N, Gowing G, Julien JP, Lacroix S. Requirement of myeloid cells for axon regeneration. J Neurosci 2008, 28:9363-9376. 10.1523/JNEUROSCI.1447-08.2008, 18799670.
142. Lu X, Richardson PM. Inflammation near the nerve cell body enhances axonal regeneration. J Neurosci 1991, 11:972-978.
143. Whetstone WD, Hsu JY, Eisenberg M, Werb Z, Noble-Haeusslein LJ. Blood-spinal cord barrier after spinal cord injury: relation to revascularization and wound healing. J Neurosci Res 2003, 74:227-239. 10.1002/jnr.10759, 2837839, 14515352.
144. Fawcett JW. Overcoming inhibition in the damaged spinal cord. J Neurotrauma 2006, 23:371-383. 10.1089/neu.2006.23.371, 16629623.
145. Yiu G, He Z. Glial inhibition of CNS axon regeneration. Nat Rev Neurosci 2006, 7:617-627. 2693386, 16858390.
146. Barres BA, Schmid R, Sendnter M, Raff MC. Multiple extracellular signals are required for long-term oligodendrocyte survival. Development 1993, 118:283-295.
147. Casha S, Yu WR, Fehlings MG. Oligodendroglial apoptosis occurs along degenerating axons and is associated with FAS and p75 expression following spinal cord injury in the rat. Neuroscience 2001, 103:203-218. 10.1016/S0306-4522(00)00538-8, 11311801.
148. Crowe MJ, Bresnahan JC, Shuman SL, Masters JN, Beattie MS. Apoptosis and delayed degeneration after spinal cord injury in rats and monkeys. Nat Med 1997, 3:73-76. 10.1038/nm0197-73, 8986744.
149. Almad A, Sahinkaya FR, McTigue DM. Oligodendrocyte fate after spinal cord injury. Neurotherapeutics 2011, 8:262-273. 10.1007/s13311-011-0033-5, 21404073.
150. Dougherty KD, Dreyfus CF, Black IB. Brain-derived neurotrophic factor in astrocytes, oligodendrocytes, and microglia/macrophages after spinal cord injury. Neurobiol Dis 2000, 7:574-585. 10.1006/nbdi.2000.0318, 11114257.
151. Ludwin SK. Phagocytosis in the rat optic nerve following Wallerian degeneration. Acta Neuropathol 1990, 80:266-273. 10.1007/BF00294644, 2399808.
152. Vaughn JE, Pease DC. Electron microscopic studies of wallerian degeneration in rat optic nerves. II. Astrocytes, oligodendrocytes and adventitial cells. J Comp Neurol 1970, 140:207-226. 10.1002/cne.901400205, 5471855.
153. Davies SJ, Goucher DR, Doller C, Silver J. Robust regeneration of adult sensory axons in degenerating white matter of the adult rat spinal cord. J Neurosci 1999, 19:5810-5822.
154. Hermanns S, Klapka N, Muller HW. The collagenous lesion scar--an obstacle for axonal regeneration in brain and spinal cord injury. Restor Neurol Neurosci 2001, 19:139-148.
155. Kigerl KA, Gensel JC, Ankeny DP, Alexander JK, Donnelly DJ, Popovich PG. Identification of two distinct macrophage subsets with divergent effects causing either neurotoxicity or regeneration in the injured mouse spinal cord. J Neurosci 2009, 29:13435-13444. 10.1523/JNEUROSCI.3257-09.2009, 2788152, 19864556.
156. Mosser DM, Edwards JP. Exploring the full spectrum of macrophage activation. Nat Rev Immunol 2008, 8:958-969. 10.1038/nri2448, 2724991, 19029990.
157. Laskin DL. Macrophages and inflammatory mediators in chemical toxicity: a battle of forces. Chem Res Toxicol 2009, 22:1376-1385. 10.1021/tx900086v, 2787782, 19645497.
158. Sica A, Schioppa T, Mantovani A, Allavena P. Tumour-associated macrophages are a distinct M2 polarised population promoting tumour progression: potential targets of anti-cancer therapy. Eur J Cancer 2006, 42:717-727. 10.1016/j.ejca.2006.01.003, 16520032.
159. Gensel JC, Nakamura S, Guan Z, van Rooijen N, Ankeny DP, Popovich PG. Macrophages promote axon regeneration with concurrent neurotoxicity. J Neurosci 2009, 29:3956-3968. 10.1523/JNEUROSCI.3992-08.2009, 2693768, 19321792.
160. Becerra JL, Puckett WR, Hiester ED, Quencer RM, Marcillo AE, Post MJ, Bunge RP. MR-pathologic comparisons of wallerian degeneration in spinal cord injury. AJNR Am J Neuroradiol 1995, 16:125-133.
161. Buss A, Brook GA, Kakulas B, Martin D, Franzen R, Schoenen J, Noth J, Schmitt AB. Gradual loss of myelin and formation of an astrocytic scar during Wallerian degeneration in the human spinal cord. Brain 2004, 127:34-44. 10.1093/brain/awh001, 14534158.
162. Vallieres N, Berard JL, David S, Lacroix S. Systemic injections of lipopolysaccharide accelerates myelin phagocytosis during Wallerian degeneration in the injured mouse spinal cord. Glia 2006, 53:103-113. 10.1002/glia.20266, 16206158.
163. Gladson CL. The extracellular matrix of gliomas: modulation of cell function. J Neuropathol Exp Neurol 1999, 58:1029-1040. 10.1097/00005072-199910000-00001, 10515226.
164. Bellail AC, Hunter SB, Brat DJ, Tan C, Van Meir EG. Microregional extracellular matrix heterogeneity in brain modulates glioma cell invasion. Int J Biochem Cell Biol 2004, 36:1046-1069. 10.1016/j.biocel.2004.01.013, 15094120.
165. McKeon RJ, Schreiber RC, Rudge JS, Silver J. Reduction of neurite outgrowth in a model of glial scarring following CNS injury is correlated with the expression of inhibitory molecules on reactive astrocytes. J Neurosci 1991, 11:3398-3411.
166. Chen MS, Huber AB, van der Haar ME, Frank M, Schnell L, Spillmann AA, Christ F, Schwab ME. Nogo-A is a myelin-associated neurite outgrowth inhibitor and an antigen for monoclonal antibody IN-1. Nature 2000, 403:434-439. 10.1038/35000219, 10667796.
167. GrandPre T, Nakamura F, Vartanian T, Strittmatter SM. Identification of the Nogo inhibitor of axon regeneration as a Reticulon protein. Nature 2000, 403:439-444. 10.1038/35000226, 10667797.
168. Zheng B, Atwal J, Ho C, Case L, He XL, Garcia KC, Steward O, Tessier-Lavigne M. Genetic deletion of the Nogo receptor does not reduce neurite inhibition in vitro or promote corticospinal tract regeneration in vivo. Proc Natl Acad Sci USA 2005, 102:1205-1210. 10.1073/pnas.0409026102, 544342, 15647357.
169. Lee JK, Geoffroy CG, Chan AF, Tolentino KE, Crawford MJ, Leal MA, Kang B, Zheng B. Assessing spinal axon regeneration and sprouting in Nogo-, MAG-, and OMgp-deficient mice. Neuron 2010, 66:663-670. 10.1016/j.neuron.2010.05.002, 2896331, 20547125.
170. Lee JK, Chow R, Xie F, Chow SY, Tolentino KE, Zheng B. Combined genetic attenuation of myelin and semaphorin-mediated growth inhibition is insufficient to promote serotonergic axon regeneration. J Neurosci 2010, 30:10899-10904. 10.1523/JNEUROSCI.2269-10.2010, 2974627, 20702718.